Skip to main content

RDHL · RedHill Biopharma Ltd. · Proposed Sales

Track RDHL — free
$0.43 +0.05 (+12.67%) Q1 2022 earnings call transcript
Market Cap
$3.39M
Shares
8.89M
Volume · Nov 12 71.63K Avg daily vol (3M) 2.05M

Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.

No Proposed Sales

No Form 144 proposed-sale notices are available for this stock yet.

Key facts CIK 1553846 CUSIP 757468301 13F (30d) 9 filings 9 filers Visit website Investor relations